Flow Pharma offers a T-Cell based vaccine delivery platform with 10 issued patents, 24 pending, and 10 published scientific articles.
Flow Pharma has raised $225K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Flow Pharma is headquartered in Cleveland, United States.
Flow Pharma offers a T-Cell based vaccine delivery platform with 10 issued patents, 24 pending, and 10 published scientific articles.
Flow Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flow Pharma — Funding & Investors." VCBacked, August 1, 2024, https://www.vcbacked.co/company/flow-pharma. Accessed August 15, 2026.
VCBacked. (2024). Flow Pharma — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/flow-pharma
{{cite web |title=Flow Pharma — Funding & Investors |url=https://www.vcbacked.co/company/flow-pharma |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated